Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis

Duffy, 1990, Urokinase-plasminogen activator, a new, and independent prognostic marker in breast cancer, Cancer Res, 50, 6827 Gettins, 1992, Structure and mechanism of action of serpins, Hemat Oncol Clin of North Am, 6, 1393, 10.1016/S0889-8588(18)30282-X Potempa, 1994, The serpin superfamily of proteinase inhibitors, J Biol Chem, 269, 15957, 10.1016/S0021-9258(17)33954-6 Chen, 1992, Membrane proteases, Curr Opin Cell Biol, 4, 802, 10.1016/0955-0674(92)90103-J Bianchi, 1995, Immunochistochemical localizations of the plasminogen activator inhibitor-1 in breast cancer, J Cancer, 60, 597 Schmitt, 1995, Clinical impact of the plasminogen activation system in tumor invasion and metastasis, Thromb Haemost, 78, 285 Janicke, 1994, Both cytosols and detergent extract of breast cancer tissue are suited to evaluate the prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1, Cancer Res, 54, 2527 Sheng, 1994, Production, purification, and characterization of recombinant maspin proteins, J Biol Chem., 269, 30988, 10.1016/S0021-9258(18)47379-6 Zou, 1994, Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells, Science, 263, 526, 10.1126/science.8290962 Maass N, Teffner M, Rösel F, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J Pathol (in press). Zhang, 1997, Transactivation through Ets and Ap1 transcriptional sites determines the expression of the tumor-suppressing gene maspin, Cell Growth Differ, 8, 179 Maass, 1997, Transkriptionelle Regulierung von Protease-Inhibitor Maspin in Brustepithel-u, Brusttumor-Zellen Tu Diag Ther, 18, 89 Sheng, 1996, Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells, Proc Natl Acad Sci USA, 93, 11669, 10.1073/pnas.93.21.11669 Zou, 2000, p53 regulates the expression of tumor suppressor gene maspin, J Biol Chem, 275, 6051, 10.1074/jbc.275.9.6051 Zhang, 2000, Maspin is an angiogenesis inhibitor, Nat Med, 6, 196, 10.1038/72303 Luppi, 1996, Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene, Ann Oncol, 7, 619, 10.1093/oxfordjournals.annonc.a010680 Scarff, 1986 Bloom, 1957, Histological grading and prognosis in breast cancer, Br J Cancer, 11, 359, 10.1038/bjc.1957.43 1992 Chomczynsky, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156 Domann, 2000, Epigenetic silencing of maspin gene expression in human breast cancer, Int J Cancer, 85, 805, 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5 Weidner, 2000, Angiogenesis as a predictor of clinical outcome in cancer patients, Hum Pathol, 31, 403, 10.1053/hp.2000.6724 Xia, 2000, High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma, Oncogene, 19, 2398, 10.1038/sj.onc.1203535 Elston, 1991, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer, Histopathology, 19, 403, 10.1111/j.1365-2559.1991.tb00229.x Pereira, 1995, Pathological prognostic factors in breast cancer. IV. Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma, Histopathology, 27, 219, 10.1111/j.1365-2559.1995.tb00213.x Horiguchi, 1994, Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer, Oncology, 51, 47, 10.1159/000227309 Winstanley, 1991, The long term prognostic significance of c-erbB-2 in primary breast cancer, Br J Cancer, 63, 447, 10.1038/bjc.1991.103 Sabbatini, 2000, Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy, J Clin Oncol, 18, 1914, 10.1200/JCO.2000.18.9.1914 Merrie, 1999, Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer, Br J Cancer, 80, 2019, 10.1038/sj.bjc.6690636 López-Guerrero, 1999, Use of reverse-transecriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer, J Hematother, 8, 53, 10.1089/106161299320578